Ritika Sharma
Moderate risk34 yrs · Female · UHID RP-10482 · +91 98450 11223
Type 2 Diabetes · Dyslipidaemia
Last seen
2 days ago
14 visits so far
Next visit
18 Aug 2026 · HbA1c review
Confirmed
Active meds
2 running
Metformin 500mg
Watch labs
3
HbA1c
AI clinical summary
Glycaemic control improving (HbA1c 8.1% → 7.4% over 6 months) with 84% Metformin adherence. BMI down 1.8 points on the Diabetes Club diet track. Missed the last podiatry review. Recommend repeat HbA1c in 8 weeks, add microalbuminuria screening, and invite to the Diabetes Club for peer accountability — cohort data shows +26% adherence for club members.
No pre-visit form on file — ask the patient to share present and past symptoms with reports.
Next best actions
- Invite to Diabetes Club (peers improve adherence by 26%)
- Schedule microalbuminuria screening with next HbA1c
- Send podiatry re-book reminder — 41 days overdue
Current medicines
Metformin 500mg
1-0-1 after food · since Feb 2026
Atorvastatin 10mg
0-0-1 · since Apr 2026
Recent labs
- HbA1c7.4%
- Fasting glucose132 mg/dL
- LDL112 mg/dL
- Creatinine0.8 mg/dL
Latest vitals
BP
128/82
-4 vs last
Weight
68.4 kg
-2.1 kg
BMI
26.1
-1.8
Pulse
78 bpm
stable
At a glance
Visits
14
Last 2 days ago
Next visit
18 Aug 2026 · HbA1c review
Lifetime value
₹48,600
Outstanding
₹0